The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: Endorsed by the world heart federation

Journal of the American College of Cardiology

Volumn 62, Issue 22, 2013, Pages 2046-2072

  Arbustini, Eloisa ^a   Narula, Navneet ^b   Dec, G William ^c   Reddy, K Srinath ^d   Greenberg, Barry ^e   Kushwaha, Sudhir ^f   Marwick, Thomas ^g   Pinney, Sean ^h   Bellazzi, Riccardo ⁱ   Favalli, Valentina ^a   Kramer, Christopher ^j   Roberts, Robert ^k   Zoghbi, William A ^l   Bonow, Robert ^m   Tavazzi, Luigi ⁿ   Fuster, Valentin ^h   Narula, Jagat ^h  

^a Cardiovascular Pathology   (Italy)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Mayo Clinic   (United States)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h MOUNT SINAI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF PAVIA   (Italy)

^j UNIVERSITY OF VIRGINIA   (United States)

^k UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^l HOUSTON METHODIST HOSPITAL   (United States)

^m Center for Cardiovascular Research   (United States)

ⁿ MARIA CECILIA HOSPITAL   (Italy)

more..

Author keywords

cardiomyopathy; diastolic dysfunction; heart failure; heart muscle disease; myocardial hypertrophy; systolic dysfunction; ventricular arrhythmias

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUTATIONAL ANALYSIS; NOMENCLATURE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; VENTRICULAR NONCOMPACTION;

EID: 84888331101     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.1644     Document Type: Review

References (94)

1. M.A. Blankerhorn, and E.A. Gall Myocarditis and myocardosis: a clinicopathologic appraisal Circulation 13 1956 217 223
2. W. Brigden Uncommon myocardial diseases; the non-coronary cardiomyopathies Lancet 273 1957 1179 1184
3. J.F. Goodwin, and C.M. Oakley The cardiomyopathies Br Heart J 34 1972 545 552
4. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies Br Heart J 44 1980 672 673
5. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
6. H.A. Snellen Birth and growth of the European Society of Cardiology Eur Heart J 1 1980 5 7
7. B.J. Maron, J.A. Towbin, G. Thiene American Heart Association, Council on Clinical Cardiology, Heart Failure and Transplantation Committee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
8. P. Elliott, B. Andersson, and E. Arbustini Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
9. R.E. Hershberger, and J.D. Siegfried Update 2011: clinical and genetic issues in familial dilated cardiomyopathy J Am Coll Cardiol 57 2011 1641 1649
10. P. Charron, M. Arad, and E. Arbustini Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 3 2010 2715 2726
11. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 61 2013 e6 e75
12. A.E. Epstein, J.P. Di Marco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guidelines Update for Implantation of Cardiac Pacemakers and Antiarrhythmic Devices) J Am Coll Cardiol 51 2008 e1 e62
13. A.M. Russo, R.F. Steinback, and S.R. Bailey ACCF/HRS/AHA/ASE/HFSA/SCAI/ SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter- defibrillator and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society of Cardiovascular Angiography and Intervention, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J Am Coll Cardiol 61 2013 1323 1373
14. P. Sorajja, P.M. Elliott, and W.J. McKenna The molecular genetics of hypertrophic cardiomyopathy: prognostic implications Europace 2 2000 4 14
15. I.A. van Rijsingen, E. Arbustini, and P.M. Elliott Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study J Am Coll Cardiol 59 2012 493 500
16. M. Diegoli, M. Grasso, and V. Favalli Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects J Am Coll Cardiol 58 2011 925 934
17. D. Corrado, C. Basso, and G. Thiene Is it time to include ion channel diseases among cardiomyopathies? J Electrocardiol 38 Suppl 2005 81 87
18. S. Pankuweit, A. Richter, V. Ruppert, and B. Maisch Classification of cardiomyopathies and indication for endomyocardial biopsy revisited Herz 34 2009 55 62
19. G. Webster, and C.I. Berul An update on channelopathies: from mechanisms to management Circulation 127 2013 126 140
20. M. Pasotti, C. Klersy, and A. Pilotto Long-term outcome and risk stratification in dilated cardiolaminopathies J Am Coll Cardiol 52 2008 1250 1260
21. K.G. Claeys, P.F. van der Ven, and A. Behin Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study Acta Neuropathol 117 2009 293 307
22. P. von Nandelstadh, R. Soliymani, M. Baumann, and O. Carpen Analysis of myotilin turnover provides mechanistic insight into the role of myotilinopathy-causing mutations Biochem J 436 2011 113 121
23. A. Ferlini, M. Neri, and F. Gualandi The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice Neuromuscul Disord 23 2013 4 14
24. C.S. Clemen, H. Herrmann, S.V. Strelkov, and R. Schröder Desminopathies: pathology and mechanisms Acta Neuropathol 125 2013 47 75
25. C. Bruno, F. Sotgia, E. Gazzerro, C. Minetti, and M.P. Lisanti Caveolinopathies R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam, GeneReviews [Internet]. Updated September 6, 2012 2012 University of Washington Seattle Seattle, WA
26. G. Bonne, F. Leturcq, and R. Ben Yaou Emery Dreifuss muscle dystrophy R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam, GeneReviews [Internet]. Updated January 17, 2013 2013 University of Washington Seattle Seattle, WA
27. G. Piccolo, G. Azan, and P. Tonin Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy Neuromuscul Disord 4 1994 143 146
28. J. Niezgoda, and P.G. Morgan Anesthetic considerations in patients with mitochondrial defects Paediatr Anaesth 23 2013 785 793
29. C.A. Galimberti, M. Diegoli, and I. Sartori Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation Neurology 67 2006 1715 1717
30. P. Van Der Starre, T. Deuse, C. Pritts, C. Brun, H. Vogel, and P. Oyer Late profound muscle weakness following heart transplantation due to Danon disease Muscle Nerve 47 2013 135 137
31. C. Brodt, J.D. Siegfried, and M. Hofmeyer Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy J Card Fail 19 2013 233 239
32. National Cancer Institute. Cancer Staging. Available at: http://www.cancer.gov/cancertopics/factsheet/detection/staging. Accessed August 2, 2013.
33. K.Y. van Spaendonck-Zwarts, I.A. van Rijsingen, and M.P. van den Berg Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience Eur J Heart Fail 15 2013 628 636
34. H. Abriel, and E.V. Zaklyazminskaya Cardiac channelopathies: genetic and molecular mechanisms Gene 517 2013 1 11
35. C. Rapezzi, E. Arbustini, and A.P.L. Caforio Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 1448 1458
36. ®). Available at: http://www.nlm.nih.gov/research/umls/ Snomed/snomed-main.html. Accessed August 2, 2013.
37. International Health Terminology Standards Development Organisation. SNOMED CT. Available at: http://www.ihtsdo.org/snomed-ct/. Accessed August 2, 2013.
38. World Health Organization. International Classification of Diseases (ICD). Available at: http://www.who.int/classifications/icd/en/. Accessed August 2, 2013.
39. L.R. Lopes, M.S. Rahman, and P.M. Elliott A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations Heart 2013 May 14 [E-pub ahead of print]
40. T.M. Olson, M.L. Karst, F.G. Whitby, and D.J. Driscoll Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology Circulation 105 2002 2337 2340
41. B.J. Maron, M.S. Maron, and C. Semsarian Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors Heart Rhythm 9 2012 57 63
42. T. Tsoutsman, R.D. Bagnall, and C. Semsarian Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure Clin Exp Pharmacol Physiol 35 2008 1349 1357
43. M. Arad, B.J. Maron, and J.M. Gorham Glycogen storage diseases presenting as hypertrophic cardiomyopathy N Engl J Med 352 2005 362 372
44. R.M. Payne, and G.R. Wagner Cardiomyopathy in Friedreich ataxia: clinical findings and research J Child Neurol 27 2012 1179 1186
45. B.J. Maron, W.C. Roberts, and M. Arad Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy JAMA 301 2009 1253 1259
46. F.I. Gambarin, E. Disabella, and J. Narula When should cardiologists suspect Anderson-Fabry disease? Am J Cardiol 106 2010 1492 1499
47. L.W. Katzin, and A.A. Amato Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy J Clin Neuromuscul Dis 9 2008 421 431
48. M.G. Bates, J.P. Bourke, C. Giordano, G. d'Amati, D.M. Turnbull, and R.W. Taylor Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management Eur Heart J 33 2012 3023 3033
49. P.F. Chinnery, and G. Hudson Mitochondrial genetics Br Med Bull 106 2013 135 159
50. R.N. Hadley, and J.W.C. Hagstrom Cardiac lesions in a patient with familial neurovisceral lipidosis (generalized gangliosidosis) Am J Clin Path 55 1971 237 240
51. P.F. Benson, A. Babarik, S.P. Brown, and T.P. Mann GM1-generalized gangliosidosis variant with cardiomegaly Postgrad Med J 52 1976 159 165
52. A. Kohlschutter, K. Sieg, F.J. Schulte, H.V. Hayek, and H.H. Goebel Infantile cardiomyopathy and neuromyopathy with beta-galactosidase deficiency Eur J Pediat 139 1982 75 81
53. H. Rosenberg, T.C. Freeman, and M.D. Li Cardiac involvement in diseases characterized by beta-galactosidase deficiency J. Pediat 106 1985 78 80
54. P. Venugopalan, and S.N. Joshi Cardiac involvement in infantile Sandhoff disease J Paediatr Child Health 38 2002 98 100
55. W. Krivit, R.J. Desnick, and J. Lee Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease) Am J Med 52 1972 763 770
56. M.M. McGovern, N. Lippa, E. Bagiella, E.H. Schuchman, R.J. Desnick, and M.P. Wasserstein Morbidity and mortality in type B Niemann-Pick disease Genet Med 15 2013 618 623
57. E. Arbustini, P. Morbini, and M. Grasso Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits J Am Coll Cardiol 31 1998 645 653
58. E. Arbustini, M. Pasotti, and A. Pilotto Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects Eur J Heart Fail 8 2006 477 483
59. F.I. Gambarin, M. Tagliani, and E. Arbustini Pure restrictive cardiomyopathy associated with cardiac troponin I gene mutation: mismatch between the lack of hypertrophy and the presence of disarray Heart 94 2008 1257
60. C. Fiset, and W.R. Giles Cardiac troponin T mutations promote life-threatening arrhythmias J Clin Invest 118 2008 3845 3847
61. F. Pasquale, P. Syrris, J.P. Kaski, J. Mogensen, W.J. McKenna, and P. Elliott Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene Circ Cardiovasc Genet 5 2012 10 17
62. K.Y. van Spaendonck-Zwarts, L. van Hessem, and J.D. Jongbloed Desmin-related myopathy Clin Genet 80 2011 354 366
63. J. Mogensen, and E. Arbustini Restrictive cardiomyopathy Curr Opin Cardiol 24 2009 214 220
64. G. Merlini, and V. Bellotti Molecular mechanisms of amyloidosis N Engl J Med 349 2003 583 596
65. E. Arbustini, L. Verga, M. Concardi, G. Palladini, L. Obici, and G. Merlini Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis Amyloid 9 2002 108 114
66. C.C. Quarta, J.L. Kruger, and R.H. Falk Cardiac amyloidosis Circulation 126 2012 e178 e182
67. Y. Bilginer, T. Akpolat, and S. Ozen Renal amyloidosis in children Pediatr Nephrol 26 2011 1215 1227
68. J.N. Dungu, L.J. Anderson, C.J. Whelan, and P.N. Hawkins Cardiac transthyretin amyloidosis Heart 98 2012 1546 1554
69. L. Obici, V. Bellotti, and P. Mangione The new apolipoprotein A-I variant leu(174) -> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide Am J Pathol 155 1999 695 702
70. R.E. Hershberger, J. Lindenfeld, L. Mestroni, C.E. Seidman, M.R.G. Taylor, and J.A. Towbin Heart Failure Society of America. Genetic evaluation of cardiomyopathy - A Heart Failure Society of America practice guideline J Card Fail 15 2009 83 97
71. G. Millat, P. Bouvagnet, and P. Chevalier Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy Eur J Med Genet 54 2011 e570 e575
72. E. Arbustini, M. Diegoli, and P. Morbini Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy J Am Coll Cardiol 35 2000 1760 1768
73. D.S. Herman, L. Lam, and M.R. Taylor Truncations of titin causing dilated cardiomyopathy N Engl J Med 366 2012 619 628
74. S.F. Nagueh, G. Shah, and Y. Wu Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy Circulation 110 2004 155 162
75. G. Quarta, P. Syrris, and M. Ashworth Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy Eur Heart J 33 2012 1128 1136
76. M. Vatta, B. Mohapatra, and S. Jimenez Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction J Am Coll Cardiol 42 2003 2014 2027
77. C. Rigaud, A.S. Lebre, and R. Touraine Natural history of Barth syndrome: a national cohort study of 22 patients Orphanet J Rare Dis 8 2013 70
78. R.K.J. Olsen, B.S. Andresen, E. Christensen, P. Bross, F. Skovby, and N. Gregersen Clear relationship between ETF/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency Hum Mutat 22 2003 12 23
79. J.B. Lundemose, S. Kolvraa, N. Gregersen, E. Christensen, and M. Gregersen Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years Molec Path 50 1997 212 217
80. M. Singla, G. Guzman, and A.J. Griffin Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency: a clinico-pathological correlation and review of literature Pediatr Cardiol 29 2008 446 451
81. P.L. Magoulas, and A.W. El-Hattab Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management Orphanet J Rare Dis 7 2012 68
82. C. Lefevre, F. Jobard, and F. Caux Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome Am J Hum Genet 69 2001 1002 1012
83. W.C. Liang, and I. Nishino State of the art in muscle lipid diseases Acta Myol 29 2010 351 356
84. A. Yamak, F. Bitar, P. Karam, and G. Nemer Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation Clin Genet 72 2007 59 62
85. K. Shibbani, A. Fahed, and L. Al-Shaar Primary carnitine deficiency: novel mutations and insights into the cardiac phenotype Clin Genet 2013 Feb 4 [E-pub ahead of print]
86. S. Sen-Chowdhry, P. Syrris, and S.K. Prasad Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity J Am Coll Cardiol 52 2008 2175 2187
87. M.J. Ackerman, S.G. Priori, S. Willems Heart Rhythm Society (HRS), European Heart Rhythm Association (EHRA) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies Europace 13 2011 1077 1109
88. F.I. Marcus, S. Edson, and J.A. Towbin Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians J Am Coll Cardiol 61 2013 1945 1948
89. P. Garcia-Pavia, P. Syrris, and C. Salas Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study Heart 97 2011 1744 1752
90. M.V. Zaragoza, E. Arbustini, and J. Narula Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology Curr Opin Pediatr 19 2007 619 627
91. T.E. Paterick, M.M. Umland, and M.F. Jan Left ventricular noncompaction: a 25-year odyssey J Am Soc Echocardiogr 25 2012 363 375
92. N.L. Bhatia, A.J. Tajik, S. Wilansky, D.E. Steidley, and F. Mookadam Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview J Card Fail 17 2011 771 778
93. S. Klaassen, S. Probst, and E. Oechslin Mutations in sarcomere protein genes in left ventricular noncompaction Circulation 117 2008 2893 2901
94. S.L. Clarke, A. Bowron, and I.L. Gonzalez Barth syndrome Orphanet J Rare Dis 8 2013 23